Skip to main content
Erschienen in: Current Allergy and Asthma Reports 6/2013

01.12.2013 | FOOD ALLERGY (D ATKINS, SECTION EDITOR)

Is There a Role for Probiotics in the Prevention or Treatment of Food Allergy?

verfasst von: Merja Nermes, Seppo Salminen, Erika Isolauri

Erschienen in: Current Allergy and Asthma Reports | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

A balanced gut microbiota is crucial for the development of healthy immunoregulation and gut barrier function to allow brisk immune responses to pathogens and systemic hyporesponsiveness to harmless antigens such as food. Although the first allergic disease to manifest itself, atopic eczema, is not equivalent to food allergy, pre- and postnatal administration of specific probiotic strains has emerged as a promising tool for the prevention of this condition, with potential implications for food allergy development. For food allergy proper, however, we lack markers and risk factors and mechanisms, i.e., targets for preventive measures. The focus here is therefore on the treatment. Indeed, the potential of specific probiotic strains to alleviate food allergy resides in their ability to modify antigens, repair gut barrier functions, balance altered microbiota, and restore local and systemic immune regulation. In patients with multiple food allergies, induction of oral tolerance by specific probiotics continues to attract research interest.
Literatur
2.
Zurück zum Zitat Rona RJ, Keil T, Summers C, Gislason D, Zuidemeer, Sodergren E, et al. The prevalence of food allergy: a meta-analysis. J Allergy Clin Immunol. 2007;120:638–46.PubMedCrossRef Rona RJ, Keil T, Summers C, Gislason D, Zuidemeer, Sodergren E, et al. The prevalence of food allergy: a meta-analysis. J Allergy Clin Immunol. 2007;120:638–46.PubMedCrossRef
3.
Zurück zum Zitat Dupont C. Food allergy: recent advances in pathophysiology and diagnosis. Ann Nutr Metab. 2011;59(suppl):8–18.PubMedCrossRef Dupont C. Food allergy: recent advances in pathophysiology and diagnosis. Ann Nutr Metab. 2011;59(suppl):8–18.PubMedCrossRef
4.
Zurück zum Zitat Nylund L, Satokari R, Nikkilä J, Rajilic-Stojanovic M, Kalliomäki M, Isolauri E, et al. Microarray analysis reveals marked intestinal microbiota aberrancy in infants having eczema compared to healthy children in at-risk atopic disease. BMC Microbiol. 2013 Jan;23:12. doi:10.1186/1471-2180-13-12. Nylund L, Satokari R, Nikkilä J, Rajilic-Stojanovic M, Kalliomäki M, Isolauri E, et al. Microarray analysis reveals marked intestinal microbiota aberrancy in infants having eczema compared to healthy children in at-risk atopic disease. BMC Microbiol. 2013 Jan;23:12. doi:10.​1186/​1471-2180-13-12.
5.
Zurück zum Zitat Hersoug LG, Linneberg A. The link between the epidemics of obesity and allergic diseases: does obesity induce decreased immune tolerance? Allergy. 2007;62:1205–13.PubMedCrossRef Hersoug LG, Linneberg A. The link between the epidemics of obesity and allergic diseases: does obesity induce decreased immune tolerance? Allergy. 2007;62:1205–13.PubMedCrossRef
6.
Zurück zum Zitat Mai XM, Becker AB, Sellers EA, Liem JJ, Kozyrskyj AL. The relationship of breastfeeding, overweight and asthma in preadolescents. J Allergy Clin Immunol. 2007;120:551–6.PubMedCrossRef Mai XM, Becker AB, Sellers EA, Liem JJ, Kozyrskyj AL. The relationship of breastfeeding, overweight and asthma in preadolescents. J Allergy Clin Immunol. 2007;120:551–6.PubMedCrossRef
7.
Zurück zum Zitat Kero J, Gissler M, Hemminki E, Isolauri E. Could the Th1 and Th2 diseases coexist? Evaluation of asthma incidence in children with celiac disease, type 1 diabetes or rheumatoid arthiritis. A register study. J Allergy Clin Immunol. 2001;108:781–3.PubMedCrossRef Kero J, Gissler M, Hemminki E, Isolauri E. Could the Th1 and Th2 diseases coexist? Evaluation of asthma incidence in children with celiac disease, type 1 diabetes or rheumatoid arthiritis. A register study. J Allergy Clin Immunol. 2001;108:781–3.PubMedCrossRef
8.
Zurück zum Zitat Sicherer SH. Determinants of systemic manifestation of food allergy. J Allergy Clin Immunol. 2000;106:S251–7.PubMedCrossRef Sicherer SH. Determinants of systemic manifestation of food allergy. J Allergy Clin Immunol. 2000;106:S251–7.PubMedCrossRef
9.
Zurück zum Zitat Duerkop BA, Vaishnava S, Hooper LV. Immune responses to the microbiota at the intestinal mucosal surface. Immunity. 2009;31:368–76.PubMedCrossRef Duerkop BA, Vaishnava S, Hooper LV. Immune responses to the microbiota at the intestinal mucosal surface. Immunity. 2009;31:368–76.PubMedCrossRef
10.
Zurück zum Zitat Kamada N, Nunez G. Role of the gut microbiota in the development and function of the lymphoid cells. J Immunol. 2013;190:1389–95.PubMedCrossRef Kamada N, Nunez G. Role of the gut microbiota in the development and function of the lymphoid cells. J Immunol. 2013;190:1389–95.PubMedCrossRef
11.
Zurück zum Zitat Renz H, Brandtzaeg P, Homef M. The impact of perinatal immune development on mucosal homeostasis and chronic inflammation. Nat Rev Immunol. 2011;12:9–23.PubMedCrossRef Renz H, Brandtzaeg P, Homef M. The impact of perinatal immune development on mucosal homeostasis and chronic inflammation. Nat Rev Immunol. 2011;12:9–23.PubMedCrossRef
12.
Zurück zum Zitat Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, et al. Changes in gut microbiota control inflammation in obese mice through a mechanisms involving GLP-2-driven improvement of gut permeability. Gut. 2009;58:1091–103.PubMedCrossRef Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, et al. Changes in gut microbiota control inflammation in obese mice through a mechanisms involving GLP-2-driven improvement of gut permeability. Gut. 2009;58:1091–103.PubMedCrossRef
13.
Zurück zum Zitat Peng HJ, Turner MW, Strobel S. Failure to induce oral tolerance to protein antigens in neonatal mice can be corrected by transfer of adult spleen cells. Ped Res. 1989;26:486–90.CrossRef Peng HJ, Turner MW, Strobel S. Failure to induce oral tolerance to protein antigens in neonatal mice can be corrected by transfer of adult spleen cells. Ped Res. 1989;26:486–90.CrossRef
14.
Zurück zum Zitat Isolauri E. Development of healthy gut microbiota early in life. J Paediatric Child Health. 2012;48 Suppl 3:1–6.CrossRef Isolauri E. Development of healthy gut microbiota early in life. J Paediatric Child Health. 2012;48 Suppl 3:1–6.CrossRef
15.
Zurück zum Zitat Gupta R, Sheikh A, Strachan DP, Anderson HR. Time trends in allergic disorders in the UK. Thorax. 2007;62:91–6.PubMedCrossRef Gupta R, Sheikh A, Strachan DP, Anderson HR. Time trends in allergic disorders in the UK. Thorax. 2007;62:91–6.PubMedCrossRef
16.
Zurück zum Zitat Henderson P, Wilson DC. The rising incidence of paediatric-onset inflammatory bowel disease. Arch Dis Child. 2012;97:585–6.PubMedCrossRef Henderson P, Wilson DC. The rising incidence of paediatric-onset inflammatory bowel disease. Arch Dis Child. 2012;97:585–6.PubMedCrossRef
17.
Zurück zum Zitat Salihu HM, Bonnema SM, Alio AP. Obesity: what is an elderly population growing into? Maturitas. 2009;63:7–12.PubMedCrossRef Salihu HM, Bonnema SM, Alio AP. Obesity: what is an elderly population growing into? Maturitas. 2009;63:7–12.PubMedCrossRef
18.
Zurück zum Zitat Satokari R, Grönroos T, Laitinen K, Salminen S, Isolauri E. Bifidobacterium and Lactobacillus DNA in the human placenta. Lett Appl Microbiol. 2009;48:8–12.PubMedCrossRef Satokari R, Grönroos T, Laitinen K, Salminen S, Isolauri E. Bifidobacterium and Lactobacillus DNA in the human placenta. Lett Appl Microbiol. 2009;48:8–12.PubMedCrossRef
19.
Zurück zum Zitat Jiménez E, Fernández L, Marín ML, Martín R, Odriozola JM, Nueno-Palop C, et al. Isolation of commensal bacteria from umbilical cord blood of healthy neonates born by caesarean section. Curr Microbiol. 2005;51:270–4.PubMedCrossRef Jiménez E, Fernández L, Marín ML, Martín R, Odriozola JM, Nueno-Palop C, et al. Isolation of commensal bacteria from umbilical cord blood of healthy neonates born by caesarean section. Curr Microbiol. 2005;51:270–4.PubMedCrossRef
20.
Zurück zum Zitat Perez PF, Doré J, Leclerc M, Levenez F, Benyacoub J, Serrant P, et al. Bacterial imprinting of the neonatal immune system: lessons from maternal cells? Pediatrics. 2007;119:e724–32.PubMedCrossRef Perez PF, Doré J, Leclerc M, Levenez F, Benyacoub J, Serrant P, et al. Bacterial imprinting of the neonatal immune system: lessons from maternal cells? Pediatrics. 2007;119:e724–32.PubMedCrossRef
21.
Zurück zum Zitat • Rautava S, Collado MC, Salminen S, Isolauri E. Probiotics modulate host-microbe interaction in the placenta and fetal gut: a randomized double-blind placebo-controlled trial. Neonatology. 2012;102:178–84. The study showed that maternal supplementation of Bifidobacterium lactis and B. lactis in combination with Lactobacillus rhamnosus GG for 14 days before elective caesarean section modulated the expression of Toll-like receptor-related genes in the placenta and in the fetal gut.PubMedCrossRef • Rautava S, Collado MC, Salminen S, Isolauri E. Probiotics modulate host-microbe interaction in the placenta and fetal gut: a randomized double-blind placebo-controlled trial. Neonatology. 2012;102:178–84. The study showed that maternal supplementation of Bifidobacterium lactis and B. lactis in combination with Lactobacillus rhamnosus GG for 14 days before elective caesarean section modulated the expression of Toll-like receptor-related genes in the placenta and in the fetal gut.PubMedCrossRef
22.
Zurück zum Zitat Koren O, Goodrich JK, Cullender TC, Spor A, Laitinen K, Bäckhed HK, et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell. 2012;150:470–80.PubMedCrossRef Koren O, Goodrich JK, Cullender TC, Spor A, Laitinen K, Bäckhed HK, et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell. 2012;150:470–80.PubMedCrossRef
23.
Zurück zum Zitat Cabrera-Rubio R, Collado MC, Laitinen K, Salminen S, Isolauri E, Mira A. The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery. Am J Clin Nutr. 2012;96:544–51.PubMedCrossRef Cabrera-Rubio R, Collado MC, Laitinen K, Salminen S, Isolauri E, Mira A. The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery. Am J Clin Nutr. 2012;96:544–51.PubMedCrossRef
24.
Zurück zum Zitat Jiménez E, Marín ML, Martín R, Odriozola JM, Olivares M, Xaus J, et al. Is meconium from healthy newborns actually sterile? Res Microbiol. 2008;59:187–93.CrossRef Jiménez E, Marín ML, Martín R, Odriozola JM, Olivares M, Xaus J, et al. Is meconium from healthy newborns actually sterile? Res Microbiol. 2008;59:187–93.CrossRef
26.
Zurück zum Zitat Favier CF, de Vos WM, Akkermans AD. Development of bacterial and bifidobacterial communities in feces of newborn babies. Anaerobe. 2003;9:219–29.PubMedCrossRef Favier CF, de Vos WM, Akkermans AD. Development of bacterial and bifidobacterial communities in feces of newborn babies. Anaerobe. 2003;9:219–29.PubMedCrossRef
27.
Zurück zum Zitat Roger LC, Costabile A, Holland DT, Hoyles L, McCartney AL. Examination of faecal Bifidobacterium populations in breast- and formula-fed infants during the first 18 months of life. Microbiology. 2010;156:3329–41.PubMedCrossRef Roger LC, Costabile A, Holland DT, Hoyles L, McCartney AL. Examination of faecal Bifidobacterium populations in breast- and formula-fed infants during the first 18 months of life. Microbiology. 2010;156:3329–41.PubMedCrossRef
28.
Zurück zum Zitat Bezirzoglou E, Tsiotsias A, Welling GW. Microbiota profile in feces of breast- and formula-fed newborns by using fluorescence in situ hybridization (FISH). Anaerobe. 2011;17:478–82.CrossRef Bezirzoglou E, Tsiotsias A, Welling GW. Microbiota profile in feces of breast- and formula-fed newborns by using fluorescence in situ hybridization (FISH). Anaerobe. 2011;17:478–82.CrossRef
29.
Zurück zum Zitat Roger LC, McCartney AL. Longitudinal investigation of the faecal microbiota of healthy full-term infants using fluorescence in situ hybridization and denaturing gradient gel electrophoresis. Microbiology. 2010;156:3317–28.PubMedCrossRef Roger LC, McCartney AL. Longitudinal investigation of the faecal microbiota of healthy full-term infants using fluorescence in situ hybridization and denaturing gradient gel electrophoresis. Microbiology. 2010;156:3317–28.PubMedCrossRef
30.
Zurück zum Zitat Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown BO. Development of the human infant intestinal microbiota. PLos Biol. 2007;5:e177.PubMedCrossRef Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown BO. Development of the human infant intestinal microbiota. PLos Biol. 2007;5:e177.PubMedCrossRef
31.
Zurück zum Zitat Azad MB, Konya T, Maughan H, Guttman DS, Field CJ, Chari RS, et al. Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months. CMAJ. 2013 Mar 19;185(5):385–94. Azad MB, Konya T, Maughan H, Guttman DS, Field CJ, Chari RS, et al. Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months. CMAJ. 2013 Mar 19;185(5):385–94.
32.
Zurück zum Zitat Gueimonde M, Laitinen K, Salminen S, Isolauri E. Breast milk: a source of bifidobacteria for infant gut development and maturation? Neonatology. 2007;92:64–6.PubMedCrossRef Gueimonde M, Laitinen K, Salminen S, Isolauri E. Breast milk: a source of bifidobacteria for infant gut development and maturation? Neonatology. 2007;92:64–6.PubMedCrossRef
33.
Zurück zum Zitat Jost T, Lacroix C, Braegger C, Chassard C. Assessment of bacterial diversity in breast milk using culture-dependent and culture-independent approaches. Br J Nutr. 2013 Mar 14:1-10. [Epub ahead of print]. Jost T, Lacroix C, Braegger C, Chassard C. Assessment of bacterial diversity in breast milk using culture-dependent and culture-independent approaches. Br J Nutr. 2013 Mar 14:1-10. [Epub ahead of print].
34.
Zurück zum Zitat Martín V, Maldonado-Barragán A, Moles L, Rodriguez-Baños M, Campo RD, Fernández L, et al. Sharing of bacterial strains between breast milk and infant feces. J Hum Lact. 2012 Feb;28(1):36–44. Martín V, Maldonado-Barragán A, Moles L, Rodriguez-Baños M, Campo RD, Fernández L, et al. Sharing of bacterial strains between breast milk and infant feces. J Hum Lact. 2012 Feb;28(1):36–44.
35.
Zurück zum Zitat Weiner HL. Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells. Microbes Infect. 2001;3:947–54.PubMedCrossRef Weiner HL. Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells. Microbes Infect. 2001;3:947–54.PubMedCrossRef
36.
Zurück zum Zitat Chen W. Dendritic cells and (CD4+)CD25+ T regulatory cells: crosstalk between two professionals in immunity versus tolerance. Front Biosci. 2006;11:1360-70. Chen W. Dendritic cells and (CD4+)CD25+ T regulatory cells: crosstalk between two professionals in immunity versus tolerance. Front Biosci. 2006;11:1360-70.
37.
Zurück zum Zitat Schultz O, Jaensson E, Persson EK, Liu X, Worbs T, Agace WW, et al. Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions. J Exp Med. 2009;206:3101–14.CrossRef Schultz O, Jaensson E, Persson EK, Liu X, Worbs T, Agace WW, et al. Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions. J Exp Med. 2009;206:3101–14.CrossRef
38.
Zurück zum Zitat Coombes JL, Siddiqui KR, Arancibia-Carcamo CV, Hall J, Sun CM, Belkaid Y, et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med. 2007;204:1757–64.PubMedCrossRef Coombes JL, Siddiqui KR, Arancibia-Carcamo CV, Hall J, Sun CM, Belkaid Y, et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med. 2007;204:1757–64.PubMedCrossRef
39.
Zurück zum Zitat Mucida D, Kutchukhidze N, Erazo A, Russo M, Lafaille JJ, Curotto de Lafaille MA. Oral tolerance in the absence of naturally occurring Tregs. J Clin Invest. 2005;115:1923–33.PubMedCrossRef Mucida D, Kutchukhidze N, Erazo A, Russo M, Lafaille JJ, Curotto de Lafaille MA. Oral tolerance in the absence of naturally occurring Tregs. J Clin Invest. 2005;115:1923–33.PubMedCrossRef
40.
Zurück zum Zitat Zhou Y, Kawasaki H, Hsu SC, Lee RT, Yao X, Plunkett B, et al. Oral tolerance to food induced systemic anaphylaxis mediated by the C-type lectin SIGNR1. Nat Med. 2010;16:1128–33.PubMedCrossRef Zhou Y, Kawasaki H, Hsu SC, Lee RT, Yao X, Plunkett B, et al. Oral tolerance to food induced systemic anaphylaxis mediated by the C-type lectin SIGNR1. Nat Med. 2010;16:1128–33.PubMedCrossRef
41.
Zurück zum Zitat Cassani B, Villablanca EJ, Quintana FJ, Love PE, Lacy-Hulbert A, Blanker WS, et al. Gut-tropic T cells that express integrin alpha4beta7 and CCR9 are required for induction of oral immune tolerance in mice. Gastroenterology. 2011;141:2109–18.PubMedCrossRef Cassani B, Villablanca EJ, Quintana FJ, Love PE, Lacy-Hulbert A, Blanker WS, et al. Gut-tropic T cells that express integrin alpha4beta7 and CCR9 are required for induction of oral immune tolerance in mice. Gastroenterology. 2011;141:2109–18.PubMedCrossRef
42.
Zurück zum Zitat Verhasselt V, Milcent V, Cazareth J, Kanda A, Fleury S, Dombrowicz D, et al. Breast milk-mediated transfer of an antigen induces tolerance and protection from allergic asthma. Nat Med. 2008;14:170–5.PubMedCrossRef Verhasselt V, Milcent V, Cazareth J, Kanda A, Fleury S, Dombrowicz D, et al. Breast milk-mediated transfer of an antigen induces tolerance and protection from allergic asthma. Nat Med. 2008;14:170–5.PubMedCrossRef
43.
Zurück zum Zitat Sudo N, Sawamura S, Taneka K, et al. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol. 1997;159:1739–45.PubMed Sudo N, Sawamura S, Taneka K, et al. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol. 1997;159:1739–45.PubMed
44.
Zurück zum Zitat Thompson-Chagoyan OC, Fallani M, Maldonato J, Vieites JM, Khanna S, Edwards C, et al. Faecal microbiota and short-chain fatty acid levels in faeces from infants with cow’s milk protein allergy. Int Arch Allergy Immunol. 2011;156:325–32.PubMedCrossRef Thompson-Chagoyan OC, Fallani M, Maldonato J, Vieites JM, Khanna S, Edwards C, et al. Faecal microbiota and short-chain fatty acid levels in faeces from infants with cow’s milk protein allergy. Int Arch Allergy Immunol. 2011;156:325–32.PubMedCrossRef
45.
Zurück zum Zitat Kalliomäki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol. 2001;107:129–34.PubMedCrossRef Kalliomäki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol. 2001;107:129–34.PubMedCrossRef
46.
Zurück zum Zitat Björkstén B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol. 2001;108:516–20.PubMedCrossRef Björkstén B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol. 2001;108:516–20.PubMedCrossRef
47.
Zurück zum Zitat Rautava S, Ruuskanen O, Ouwehand A, Salminen S, Isolauri E. The hygiene hypothesis of atopic disease- an extended version. J Pediatr Gastroenterol Nutr. 2004;38:378–88.PubMedCrossRef Rautava S, Ruuskanen O, Ouwehand A, Salminen S, Isolauri E. The hygiene hypothesis of atopic disease- an extended version. J Pediatr Gastroenterol Nutr. 2004;38:378–88.PubMedCrossRef
48.
Zurück zum Zitat Winter SE, Lopez CA, Bäumler AJ. The dynamics of gut-associated microbial communities during inflammation. EMBO Rep. 2013;14:319–27.PubMedCrossRef Winter SE, Lopez CA, Bäumler AJ. The dynamics of gut-associated microbial communities during inflammation. EMBO Rep. 2013;14:319–27.PubMedCrossRef
49.
Zurück zum Zitat FAO/WHO. Guidelines for the evaluation of probiotics in food. Food and Agricultural Organization of the United Nations and World Health Organization. Working Group Report 2002. FAO/WHO. Guidelines for the evaluation of probiotics in food. Food and Agricultural Organization of the United Nations and World Health Organization. Working Group Report 2002.
50.
Zurück zum Zitat Tuomola E, Crittenden R, Playne M, Isolauri E, Salminen S. Quality assurance criteria for probiotic bacteria. Am J Clin Nutr. 2001;73:393–8. Tuomola E, Crittenden R, Playne M, Isolauri E, Salminen S. Quality assurance criteria for probiotic bacteria. Am J Clin Nutr. 2001;73:393–8.
51.
Zurück zum Zitat Ouwehand AC, Salminen S, Tolkko S, Roberts P, Ovaska J, Salminen E. Resected human colonic tissue: new model for characterizing adhesion of lactic acid bacteria. Clin Diagn Lab Immunol. 2002;9:184–6.PubMed Ouwehand AC, Salminen S, Tolkko S, Roberts P, Ovaska J, Salminen E. Resected human colonic tissue: new model for characterizing adhesion of lactic acid bacteria. Clin Diagn Lab Immunol. 2002;9:184–6.PubMed
52.
Zurück zum Zitat Collado MC, Meriluoto J, Salminen S. Measurement of aggregation properties between probiotics and pathogens: in vitro evaluation of different methods. J Microbiol Methods. 2007;71:71–4.PubMedCrossRef Collado MC, Meriluoto J, Salminen S. Measurement of aggregation properties between probiotics and pathogens: in vitro evaluation of different methods. J Microbiol Methods. 2007;71:71–4.PubMedCrossRef
53.
Zurück zum Zitat Kankainen M, Paulin L, Tynkkynen S, von Ossowski I, Reunanen J, Partanen P, et al. Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human mucus-binding protein. Proc Natl Acad Sci U S A. 2009;106:17193–8.PubMedCrossRef Kankainen M, Paulin L, Tynkkynen S, von Ossowski I, Reunanen J, Partanen P, et al. Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human mucus-binding protein. Proc Natl Acad Sci U S A. 2009;106:17193–8.PubMedCrossRef
54.
Zurück zum Zitat Azcarate-Peril MA, Altermann E, Goh YJ, Tallon R, Sanozky-Dawes RB, Pfeiler EA, et al. Analysis of the genome sequence of Lactobacillus gasseri ATCC 33323 reveals the molecular basis of an autochthonous intestinal organism. Appl Environ Microbiol. 2008;74:4610–25.PubMedCrossRef Azcarate-Peril MA, Altermann E, Goh YJ, Tallon R, Sanozky-Dawes RB, Pfeiler EA, et al. Analysis of the genome sequence of Lactobacillus gasseri ATCC 33323 reveals the molecular basis of an autochthonous intestinal organism. Appl Environ Microbiol. 2008;74:4610–25.PubMedCrossRef
55.
Zurück zum Zitat Pessi T, Sutas Y, Marttinen A, Isolauri E. Probiotics reinforce mucosal degradation of antigens in rats: implications for therapeutic use of probiotics. J Nutr. 1998;128:2313–8.PubMed Pessi T, Sutas Y, Marttinen A, Isolauri E. Probiotics reinforce mucosal degradation of antigens in rats: implications for therapeutic use of probiotics. J Nutr. 1998;128:2313–8.PubMed
56.
Zurück zum Zitat Elo S, Saxelin M, Salminen S. Attachment of Lactobacillus casei strain GG to human colon carcinoma cell line Caco-2: comparison with other dairy strains. Lett Appl Microbiol. 1991;13:154–6.CrossRef Elo S, Saxelin M, Salminen S. Attachment of Lactobacillus casei strain GG to human colon carcinoma cell line Caco-2: comparison with other dairy strains. Lett Appl Microbiol. 1991;13:154–6.CrossRef
57.
Zurück zum Zitat Grześkowiak Ł, Isolauri E, Salminen S, Gueimonde M. Manufacturing process influences properties of probiotic bacteria. Br J Nutr. 2011 Mar;105(6):887–94. Grześkowiak Ł, Isolauri E, Salminen S, Gueimonde M. Manufacturing process influences properties of probiotic bacteria. Br J Nutr. 2011 Mar;105(6):887–94.
58.
Zurück zum Zitat Koletzko S, Niggeman B, Arato A, Dias JA, Heuschkel R, Husby S, et al. Diagnostic Approach and management of cow’s milk protein allergy in infants and children: ESGPHAN GI committee practical guidelines. J Pediatr Gastroenterol Nutr. 2012;55:221–9.PubMedCrossRef Koletzko S, Niggeman B, Arato A, Dias JA, Heuschkel R, Husby S, et al. Diagnostic Approach and management of cow’s milk protein allergy in infants and children: ESGPHAN GI committee practical guidelines. J Pediatr Gastroenterol Nutr. 2012;55:221–9.PubMedCrossRef
59.
Zurück zum Zitat Guarino A, Albano F, Ashkenazi S, Gendrel D, Hoekstra JH, Shamir R. European Society for Paediatric Gastroenterology, Hepatology, and Nutrition/European Society for Paediatric Infectious Diseases: evidence-based guidelines for the management of acute gastroenteritis in children in Europe: executive summary. J Pediatr Gastroenterol Nutr. 2008;46:619–21.PubMedCrossRef Guarino A, Albano F, Ashkenazi S, Gendrel D, Hoekstra JH, Shamir R. European Society for Paediatric Gastroenterology, Hepatology, and Nutrition/European Society for Paediatric Infectious Diseases: evidence-based guidelines for the management of acute gastroenteritis in children in Europe: executive summary. J Pediatr Gastroenterol Nutr. 2008;46:619–21.PubMedCrossRef
60.
Zurück zum Zitat van Loveren H, Sanz Y, Salminen S. Health claims in Europe: probiotics and prebiotics as case examples. Annu Rev Fo Sci Technol. 2012;3:247–61.CrossRef van Loveren H, Sanz Y, Salminen S. Health claims in Europe: probiotics and prebiotics as case examples. Annu Rev Fo Sci Technol. 2012;3:247–61.CrossRef
62.
Zurück zum Zitat Floch MH, Walker WA, Madsen K, Sanders ME, Macfarlane GT, Flint HJ, et al. Recommendations for probiotic use-2011 update. J Clin Gastroenterol. 2011 Nov;45(Suppl):S168–71. Floch MH, Walker WA, Madsen K, Sanders ME, Macfarlane GT, Flint HJ, et al. Recommendations for probiotic use-2011 update. J Clin Gastroenterol. 2011 Nov;45(Suppl):S168–71.
63.
Zurück zum Zitat van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368:407–15.PubMedCrossRef van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368:407–15.PubMedCrossRef
64.
Zurück zum Zitat Kassam Z, Lee CH, Yuan Y, Hunt RH. Fecal microbiota transplantation for Clostriudium difficile infection:systematic review and meta-analysis. Am J Gastroenterol. 2013;108:500–8.PubMedCrossRef Kassam Z, Lee CH, Yuan Y, Hunt RH. Fecal microbiota transplantation for Clostriudium difficile infection:systematic review and meta-analysis. Am J Gastroenterol. 2013;108:500–8.PubMedCrossRef
65.
Zurück zum Zitat Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet. 2001;357:1076–9.PubMedCrossRef Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet. 2001;357:1076–9.PubMedCrossRef
66.
Zurück zum Zitat Kalliomäki M, Salminen, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet. 2003;361:1869–71.PubMedCrossRef Kalliomäki M, Salminen, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet. 2003;361:1869–71.PubMedCrossRef
67.
Zurück zum Zitat Kalliomäki M, Salminen S, Poussa T, Isolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized placebo-controlled trial. J Allergy Clin Immunol. 2007;119:1019–21.PubMedCrossRef Kalliomäki M, Salminen S, Poussa T, Isolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized placebo-controlled trial. J Allergy Clin Immunol. 2007;119:1019–21.PubMedCrossRef
68.
Zurück zum Zitat Kukkonen K, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, et al. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2007;119:192–8.PubMedCrossRef Kukkonen K, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, et al. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2007;119:192–8.PubMedCrossRef
69.
Zurück zum Zitat Abrahamsson TR, Jakobsson T, Böttcher MF, Fredrikson M, Jenmalm MC, Björkstén B, et al. Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2007;119:1174–80.PubMedCrossRef Abrahamsson TR, Jakobsson T, Böttcher MF, Fredrikson M, Jenmalm MC, Björkstén B, et al. Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2007;119:1174–80.PubMedCrossRef
70.
Zurück zum Zitat Wickens K, Black P, Stanley TY, Mitchell E, Fitzharris P, Tannock GW, et al. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double blind, randomized placebo-controlled trial. J Allergy Clin Immunol. 2008;122:788–94.PubMedCrossRef Wickens K, Black P, Stanley TY, Mitchell E, Fitzharris P, Tannock GW, et al. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double blind, randomized placebo-controlled trial. J Allergy Clin Immunol. 2008;122:788–94.PubMedCrossRef
71.
Zurück zum Zitat Kuitunen M, Kukkonen K, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, et al. Probiotics prevent IgE-associated allergy until age 5 years in caesarean-delivered children but not in the total cohort. J Allergy Clin Immunol. 2009;123:335–41.PubMedCrossRef Kuitunen M, Kukkonen K, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, et al. Probiotics prevent IgE-associated allergy until age 5 years in caesarean-delivered children but not in the total cohort. J Allergy Clin Immunol. 2009;123:335–41.PubMedCrossRef
72.
Zurück zum Zitat Niers L, Martin R, Rijkers G, Sengers F, Timmerman H, van Uden NN, et al. The effects of selected probiotic strains on the development of eczema (the PandA study). Allergy. 2009;64:1349–58.PubMedCrossRef Niers L, Martin R, Rijkers G, Sengers F, Timmerman H, van Uden NN, et al. The effects of selected probiotic strains on the development of eczema (the PandA study). Allergy. 2009;64:1349–58.PubMedCrossRef
73.
Zurück zum Zitat Dotterud CK, Storro O, Johnsen R, Oien T. Probiotics in pregnant women to prevent allergic disease: a randomised, double blind trial. Br J Dermatol. 2010;163:616–23.PubMedCrossRef Dotterud CK, Storro O, Johnsen R, Oien T. Probiotics in pregnant women to prevent allergic disease: a randomised, double blind trial. Br J Dermatol. 2010;163:616–23.PubMedCrossRef
74.
Zurück zum Zitat Kim JY, Kwon JH, Ahn SH, Lee SL, Han YS, Choi Y, et al. Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, placebo-controlled trial. Pediatr Allergy Immunol. 2010;21(2Pt2):e386–93.PubMedCrossRef Kim JY, Kwon JH, Ahn SH, Lee SL, Han YS, Choi Y, et al. Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, placebo-controlled trial. Pediatr Allergy Immunol. 2010;21(2Pt2):e386–93.PubMedCrossRef
75.
Zurück zum Zitat Kopp MV, Hennemuth L, Heinzmann A, Urbanek R. Randomized, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics. 2008;121:e850–6.PubMedCrossRef Kopp MV, Hennemuth L, Heinzmann A, Urbanek R. Randomized, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics. 2008;121:e850–6.PubMedCrossRef
76.
Zurück zum Zitat Huurre A, Laitinen K, Rautava S, Korkeamäki M, Isolauri E. Impact of maternal atopy and probiotic supplementation during pregnancy on infant sensitization: a double-blind placebo-controlled study. Clin Exp Allergy. 2008;38:1342–8.PubMedCrossRef Huurre A, Laitinen K, Rautava S, Korkeamäki M, Isolauri E. Impact of maternal atopy and probiotic supplementation during pregnancy on infant sensitization: a double-blind placebo-controlled study. Clin Exp Allergy. 2008;38:1342–8.PubMedCrossRef
77.
Zurück zum Zitat Rautava S, Kainonen E, Salminen S, Isolauri E. Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. J Allergy Clin Immunol. 2012;130:1355–60.PubMedCrossRef Rautava S, Kainonen E, Salminen S, Isolauri E. Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. J Allergy Clin Immunol. 2012;130:1355–60.PubMedCrossRef
78.
Zurück zum Zitat Doege K, Grajecki D, Zyriax BC, Detinkina E, Zu Eulenburg C, Buhling KJ. Impact of maternal supplementation with probiotics during pregnancy on atopic eczema in childhood – a meta-analysis. Br J Nutr. 2012;107:1–6.PubMedCrossRef Doege K, Grajecki D, Zyriax BC, Detinkina E, Zu Eulenburg C, Buhling KJ. Impact of maternal supplementation with probiotics during pregnancy on atopic eczema in childhood – a meta-analysis. Br J Nutr. 2012;107:1–6.PubMedCrossRef
79.
Zurück zum Zitat Pelucchi C, Chatenoud L, Turati F, Galeone C, Moja L, Bach JF, et al. Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: a meta-analysis. Epidemiology. 2012;23:402–14.PubMedCrossRef Pelucchi C, Chatenoud L, Turati F, Galeone C, Moja L, Bach JF, et al. Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: a meta-analysis. Epidemiology. 2012;23:402–14.PubMedCrossRef
80.
Zurück zum Zitat Soh SE, Aw M, Gerez I, Chon YS, Rauff M, Ng YP, et al. Probiotic supplementation in the first 6 months of life in at risk Asian infants – effects on eczema and atopic sensitization at the age of 1 year. Clin Exp Allergy. 2009;39:571–8.PubMedCrossRef Soh SE, Aw M, Gerez I, Chon YS, Rauff M, Ng YP, et al. Probiotic supplementation in the first 6 months of life in at risk Asian infants – effects on eczema and atopic sensitization at the age of 1 year. Clin Exp Allergy. 2009;39:571–8.PubMedCrossRef
81.
Zurück zum Zitat Rautava S, Arvilommi H, Isolauri E. Specific probiotics in enhancing maturation of IgA responses in formula-fed infants. Pediatr Res. 2006;60:221–4.PubMedCrossRef Rautava S, Arvilommi H, Isolauri E. Specific probiotics in enhancing maturation of IgA responses in formula-fed infants. Pediatr Res. 2006;60:221–4.PubMedCrossRef
82.
Zurück zum Zitat Taylor AL, Dunstan JA, Prescott SL. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol. 2007;119:184–91.PubMedCrossRef Taylor AL, Dunstan JA, Prescott SL. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol. 2007;119:184–91.PubMedCrossRef
83.
Zurück zum Zitat West CE, Hammarstrom ML, Hernell O. Probiotics during weaning reduce the incidence of eczema. Pediatr Allergy Immunol. 2009;20:430–7.PubMedCrossRef West CE, Hammarstrom ML, Hernell O. Probiotics during weaning reduce the incidence of eczema. Pediatr Allergy Immunol. 2009;20:430–7.PubMedCrossRef
84.
Zurück zum Zitat Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol. 1997;99:179–85.PubMedCrossRef Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol. 1997;99:179–85.PubMedCrossRef
85.
Zurück zum Zitat Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy. 2000;30:1604–10.PubMedCrossRef Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy. 2000;30:1604–10.PubMedCrossRef
86.
Zurück zum Zitat Rosenfeldt V, Benfeldt E, Nielsen SD, Michaelsen KF, Jeppesen DL, Valerius NH, et al. Effect of probiotic Lactobacillus strains strains in children with atopic dermatitis. J Allergy Clin Immunol. 2003;111:389–95.PubMedCrossRef Rosenfeldt V, Benfeldt E, Nielsen SD, Michaelsen KF, Jeppesen DL, Valerius NH, et al. Effect of probiotic Lactobacillus strains strains in children with atopic dermatitis. J Allergy Clin Immunol. 2003;111:389–95.PubMedCrossRef
87.
Zurück zum Zitat Woo SI, Kim JY, Lee YJ, Kim NS, Hahn YS. Effect of Lactobacillus sakei supplementation in children with atopic eczema-dermatitis syndrome. Ann Allergy Asthma Immunol. 2010;104:343–8.PubMedCrossRef Woo SI, Kim JY, Lee YJ, Kim NS, Hahn YS. Effect of Lactobacillus sakei supplementation in children with atopic eczema-dermatitis syndrome. Ann Allergy Asthma Immunol. 2010;104:343–8.PubMedCrossRef
88.
Zurück zum Zitat Yesilova Y, Calka O, Akdeniz N, Berktas M. Effect of probiotics on the treatment of children with atopic dermatitis. Ann Dermatol. 2012;24:189–93.PubMedCrossRef Yesilova Y, Calka O, Akdeniz N, Berktas M. Effect of probiotics on the treatment of children with atopic dermatitis. Ann Dermatol. 2012;24:189–93.PubMedCrossRef
89.
Zurück zum Zitat Wu KG, Li TH, Peng HJ. Lactobacillus salivarius plus fructo-oligosaccharide is superior to fructo-oligosaccharide alone for treating children with moderate to severe atopic dermatitis: a double-blind, randomized clinical trial of efficacy and safety. Br J Dermatol. 2012;166:129–36.PubMedCrossRef Wu KG, Li TH, Peng HJ. Lactobacillus salivarius plus fructo-oligosaccharide is superior to fructo-oligosaccharide alone for treating children with moderate to severe atopic dermatitis: a double-blind, randomized clinical trial of efficacy and safety. Br J Dermatol. 2012;166:129–36.PubMedCrossRef
90.
Zurück zum Zitat Viljanen M, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, et al. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy. 2005;60:494–500.PubMedCrossRef Viljanen M, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, et al. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy. 2005;60:494–500.PubMedCrossRef
91.
Zurück zum Zitat Weston S, Halbert A, Richmond P, Prescott SL. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch Dis Child. 2005;90:892–7.PubMedCrossRef Weston S, Halbert A, Richmond P, Prescott SL. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch Dis Child. 2005;90:892–7.PubMedCrossRef
92.
Zurück zum Zitat Brouwer ML, Wolt-Plompen SA, Dubois AE, van der Heide S, Jansen DF, Hoijer MA, et al. No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. Clin Exp Allergy. 2006;36:899–906.PubMedCrossRef Brouwer ML, Wolt-Plompen SA, Dubois AE, van der Heide S, Jansen DF, Hoijer MA, et al. No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. Clin Exp Allergy. 2006;36:899–906.PubMedCrossRef
93.
Zurück zum Zitat Folster-Holst R, Muller F, Schnopp N, Abeck D, Kreiselmaier I, Lenz T. Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis. Br J Dermatol. 2006;155:1256–61.PubMedCrossRef Folster-Holst R, Muller F, Schnopp N, Abeck D, Kreiselmaier I, Lenz T. Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis. Br J Dermatol. 2006;155:1256–61.PubMedCrossRef
94.
Zurück zum Zitat Sistek D, Kelly R, Wickens K, Stanley T, Fitzharris P, Crane J. Is the effect of probiotics on atopic dermatitis confined to food sensitized children? 2006;36:629-33. Sistek D, Kelly R, Wickens K, Stanley T, Fitzharris P, Crane J. Is the effect of probiotics on atopic dermatitis confined to food sensitized children? 2006;36:629-33.
95.
Zurück zum Zitat Gruber C, Wendt M, Sulser C, Lau S, Kulig M, Wahn U, et al. Randomized, placebo-controlled trial of Lactobacilllus rhamnosus GG as treatment of atopic dermatitis in infancy. Allergy. 2007;62:1270–6.PubMedCrossRef Gruber C, Wendt M, Sulser C, Lau S, Kulig M, Wahn U, et al. Randomized, placebo-controlled trial of Lactobacilllus rhamnosus GG as treatment of atopic dermatitis in infancy. Allergy. 2007;62:1270–6.PubMedCrossRef
96.
Zurück zum Zitat Boyle RJ, Bath-Hextall FJ, Leonardi-Bee J, Murrel DF, Tang ML. Probiotics for treating eczema. Cochrane Database Syst Rev. 2008;4, CD006135.PubMed Boyle RJ, Bath-Hextall FJ, Leonardi-Bee J, Murrel DF, Tang ML. Probiotics for treating eczema. Cochrane Database Syst Rev. 2008;4, CD006135.PubMed
97.
Zurück zum Zitat Lee J, Seto D, Bielory L. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol. 2008;121:116–121e11.PubMedCrossRef Lee J, Seto D, Bielory L. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol. 2008;121:116–121e11.PubMedCrossRef
98.
Zurück zum Zitat Tang ML, Lahtinen SJ, Boyle RJ. Probiotics and prebiotics: clinical effects in allergic disease. Curr Opin Pediatr. 2010;22:626–34.PubMed Tang ML, Lahtinen SJ, Boyle RJ. Probiotics and prebiotics: clinical effects in allergic disease. Curr Opin Pediatr. 2010;22:626–34.PubMed
99.
Zurück zum Zitat Hol J, van Leer EH, Elink Schuurman BE, de Ruiter LF, Samsom JN, Hop W, et al. The acquisition of tolerance towards cow’s milk through probiotic supplementation: a randomized controlled trial. J Allergy Clin Immunol. 2008;121:1448–54.PubMedCrossRef Hol J, van Leer EH, Elink Schuurman BE, de Ruiter LF, Samsom JN, Hop W, et al. The acquisition of tolerance towards cow’s milk through probiotic supplementation: a randomized controlled trial. J Allergy Clin Immunol. 2008;121:1448–54.PubMedCrossRef
100.
Zurück zum Zitat •• Berni Canani R, Nocerino R, Terrin G, Frediani T, Lucarelli S, Cosenza L, et al. Formula selection for management of children with cow milk allergy influences the rate of acquisition of tolerance: a prospective multicenter study. J Pediatr. 2013. doi:10.1016/j.jpeds.2013.03.008. [Epub ahead of print]. Provided data that Lactobacillus rhamnosus GG enhances tolerance acquisition in extensively hydrolysed casein formula in infants with cow’s milk allergy.PubMed •• Berni Canani R, Nocerino R, Terrin G, Frediani T, Lucarelli S, Cosenza L, et al. Formula selection for management of children with cow milk allergy influences the rate of acquisition of tolerance: a prospective multicenter study. J Pediatr. 2013. doi:10.​1016/​j.​jpeds.​2013.​03.​008. [Epub ahead of print]. Provided data that Lactobacillus rhamnosus GG enhances tolerance acquisition in extensively hydrolysed casein formula in infants with cow’s milk allergy.PubMed
101.
Zurück zum Zitat Pan SJ, Kuo CH, Lam KP, Chu YT, Wang WL, Hung CH. Probiotics and allergy in infants – an update review. Pediatr Allergy Immunol. 2010;21:e659–66.PubMedCrossRef Pan SJ, Kuo CH, Lam KP, Chu YT, Wang WL, Hung CH. Probiotics and allergy in infants – an update review. Pediatr Allergy Immunol. 2010;21:e659–66.PubMedCrossRef
102.
Zurück zum Zitat Ghadimi D, Fölster-Holst R, de Vrese M, Winkler P, Heller KJ, Schrezenmeier J. Effects of probiotic bacteria and their genomic DNA on TH1/TH2-cytokine production by peripheral blood mononuclear cells (PBMCs) of healthy and allergic subjects. Immunobiology. 2008;213:677–92.PubMedCrossRef Ghadimi D, Fölster-Holst R, de Vrese M, Winkler P, Heller KJ, Schrezenmeier J. Effects of probiotic bacteria and their genomic DNA on TH1/TH2-cytokine production by peripheral blood mononuclear cells (PBMCs) of healthy and allergic subjects. Immunobiology. 2008;213:677–92.PubMedCrossRef
103.
Zurück zum Zitat Donato KA, Gareau MG, Wang YJ, Sherman PM. Lactobacillus rhamnosus GG attenuates interferon-γ and tumor-necrosis factor-α-induced barrier dysfunction and pro-inflammatory signalling. Microbiology. 2010;156:3288–97.PubMedCrossRef Donato KA, Gareau MG, Wang YJ, Sherman PM. Lactobacillus rhamnosus GG attenuates interferon-γ and tumor-necrosis factor-α-induced barrier dysfunction and pro-inflammatory signalling. Microbiology. 2010;156:3288–97.PubMedCrossRef
104.
Zurück zum Zitat Mileti E, Matteoli G, Iliev D, Rescigno M. Comparison of the immunomodulatory properties of three probiotics strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy. PLoS One. 2009;4:e7056.PubMedCrossRef Mileti E, Matteoli G, Iliev D, Rescigno M. Comparison of the immunomodulatory properties of three probiotics strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy. PLoS One. 2009;4:e7056.PubMedCrossRef
Metadaten
Titel
Is There a Role for Probiotics in the Prevention or Treatment of Food Allergy?
verfasst von
Merja Nermes
Seppo Salminen
Erika Isolauri
Publikationsdatum
01.12.2013
Verlag
Springer US
Erschienen in
Current Allergy and Asthma Reports / Ausgabe 6/2013
Print ISSN: 1529-7322
Elektronische ISSN: 1534-6315
DOI
https://doi.org/10.1007/s11882-013-0381-9

Weitere Artikel der Ausgabe 6/2013

Current Allergy and Asthma Reports 6/2013 Zur Ausgabe

Pediatric Allergy and Immunology (JM Portnoy and CE Ciaccio, Section Editors)

Indoor Water and Dampness and the Health Effects on Children: A Review

Pediatric Allergy and Immunology (JM Portnoy and CE Ciaccio, Section Editors)

Management of Rodent Exposure and Allergy in the Pediatric Population

FOOD ALLERGY (D ATKINS, SECTION EDITOR)

Food Allergy and Quality of Life: What Have We Learned?

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.